Kymera Therapeutics, Inc. (KYMR)
131.73
+3.61
(+2.82%)
USD |
NASDAQ |
Nov 06, 16:00
131.70
-0.03
(-0.02%)
After-Hours: 20:00
Kymera Therapeutics Price to Book Value : 6.962 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 6.962 |
| November 05, 2026 | 6.771 |
| November 04, 2026 | 7.201 |
| November 03, 2026 | 6.716 |
| November 02, 2026 | 6.739 |
| October 30, 2026 | 6.692 |
| October 29, 2026 | 6.479 |
| October 28, 2026 | 6.474 |
| October 27, 2026 | 6.213 |
| October 26, 2026 | 6.069 |
| October 23, 2026 | 5.854 |
| October 22, 2026 | 5.858 |
| October 21, 2026 | 5.952 |
| October 20, 2026 | 5.996 |
| October 19, 2026 | 5.711 |
| October 16, 2026 | 5.538 |
| October 15, 2026 | 5.715 |
| October 14, 2026 | 5.646 |
| October 13, 2026 | 5.638 |
| October 12, 2026 | 5.923 |
| October 09, 2026 | 5.940 |
| October 08, 2026 | 5.776 |
| October 07, 2026 | 5.726 |
| October 06, 2026 | 5.601 |
| October 05, 2026 | 5.805 |
| Date | Value |
|---|---|
| October 02, 2026 | 5.675 |
| October 01, 2026 | 5.820 |
| September 30, 2026 | 5.908 |
| September 29, 2026 | 6.062 |
| September 28, 2026 | 6.144 |
| September 25, 2026 | 6.141 |
| September 24, 2026 | 6.353 |
| September 23, 2026 | 6.334 |
| September 22, 2026 | 6.695 |
| September 21, 2026 | 6.455 |
| September 18, 2026 | 6.459 |
| September 17, 2026 | 6.499 |
| September 16, 2026 | 6.381 |
| September 15, 2026 | 6.207 |
| September 14, 2026 | 6.288 |
| September 11, 2026 | 6.306 |
| September 10, 2026 | 6.418 |
| September 09, 2026 | 6.332 |
| September 08, 2026 | 6.389 |
| September 04, 2026 | 6.439 |
| September 03, 2026 | 6.433 |
| September 02, 2026 | 6.507 |
| September 01, 2026 | 6.530 |
| August 31, 2026 | 6.517 |
| August 28, 2026 | 6.481 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Intellia Therapeutics, Inc. | 2.596 |
| Twist Bioscience Corp. | 16.98 |
| Beam Therapeutics, Inc. | 2.868 |
| C4 Therapeutics, Inc. | 1.784 |
| Arrowhead Pharmaceuticals, Inc. | 17.63 |
Price to Book Value Related Metrics
| PS Ratio | 124.25 |
| PEG Ratio | -56.91 |
| Price | 131.73 |
| Earnings Yield | -2.75% |
| Market Cap | 11.24B |
| PEGY Ratio | -56.91 |